Millennium Group (MGIH) news
Recent news
Tenax Therapeutics - To amend level-2 enrollment criteria - SEC filing
Tenax Therapeutics has announced an amendment to the level-2 enrollment criteria for one of its clinical trials, as disclosed in a recent SEC filing. The update is intended to refine patient eligibility standards to improve the precision and relevance of the study outcomes. While specific details…
AInvest Wire · 7d agoMillennium to hire Jera power trader in Japan energy push
AInvest Wire · Oct 5, 2026Millennium saw zero return in September amid volatility
Millennium Management, a prominent hedge fund known for its long-term performance, reported a zero return in September 2026 amid heightened market volatility, according to internal data. The firm, which has historically navigated turbulent markets with relative success, faced significant challenges…
AInvest Wire · Oct 1, 2026Millennium taps Citadel's Gillanders for new unit in equities
Millennium Group has appointed Citadel's Gillanders to lead the establishment of a new unit focused on equities, signaling a strategic shift to expand its presence in the equity market. The move is expected to enhance the firm's capabilities in equity research, trading, and portfolio management.…
AInvest Wire · Sep 28, 2026ImportantMillennium's new cash raise draws $30 billion in client demand
AInvest Wire · Sep 25, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.